CAS 109882-27-1

5-[(2-Chloroethyl)(2-hydroxyethyl)aMino]-1-Methyl-1H-benziMidazole-2-butanoic Acid

Description:

The chemical substance known as 5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid, with the CAS number 109882-27-1, is a synthetic compound that belongs to the class of benzimidazole derivatives. This compound features a complex structure characterized by a benzimidazole core, which is a bicyclic structure containing both benzene and imidazole rings. The presence of a chloroethyl and hydroxyethyl group suggests potential reactivity and solubility in polar solvents, while the butanoic acid moiety indicates acidic properties. The amino group in the structure may contribute to its biological activity, potentially influencing interactions with biological targets. This compound may be of interest in medicinal chemistry, particularly for its potential therapeutic applications. Its specific characteristics, such as solubility, stability, and reactivity, would depend on the surrounding conditions and the presence of other functional groups. As with many synthetic compounds, safety and handling precautions should be observed due to the presence of chlorine and other reactive functional groups.

Formula: C₁₆H₂₂ClN₃O₃

Synonyms:

• Hydroxy BendamustineDiscontinued
• Bendamustine Related Compound E
• 5-[(2-Chloroethyl)(2-hydroxyethyl)aMino]-1-Methyl-1H-benziMidazole-2-butanoic Acid
• Bendamustine impurity 5/Bendamustine USP Related Compound E/4-(1-Methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic Acid
• Bendamustine USP RC E
• Bendamustine Impurity E
• Bendamustine Impurity 4
• BendaMustine Monohydroxy IMpurity
• Bendamustine Monohydroxy Acid Impurity
• 4-(5-((2-chloroethyl)(2-hydroxyethyl)amino)
• Bendamustine impurity 5/Bendamustine USP Related Compound B/4-(1-Methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic Acid
• Hydroxy BendaMustine
• 4-(5-((2-chloroethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
• 1H-Benzimidazole-2-butanoic acid, 5-[(2-chloroethyl)(2-hydroxyethyl)amino]-1-methyl-
• Bendamustine USP Related Compound E

Bendamustine Related Compound E (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid)

CAS: 109882-27-1

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formula: C₁₆H₂₂ClN₃O₃

Color and Shape: Light Orange Solid

Molecular weight: 339.82

Ref: 45-1065276

Bendamustine USP Related Compound E

CAS: 109882-27-1

Formula: C₁₆H₂₂ClN₃O₃

Color and Shape: White To Off-White Solid

Molecular weight: 339.82

Ref: 4Z-B-431

Bendamustine USP Related Compound E-d4

CAS: 109882-27-1

Formula: C₁₆H₁₈D₄ClN₃O₃

Molecular weight: 343.84

Ref: 4Z-B-4347

Bendamustine USP Related Compound E-d8

CAS: 109882-27-1

Formula: C₁₆H₁₄D₈ClN₃O₃

Molecular weight: 347.87

Ref: 4Z-B-4348

Hydroxy bendamustine

CAS: 109882-27-1

Hydroxy bendamustine is a cytostatic agent that inhibits the proliferation of cancer cells. It is an activated benzyloxymethyl derivative of bendamustine, which is a chemical compound with cytostatic activity that belongs to the class of alkylating agents. Hydroxy bendamustine is used in the treatment of chronic lymphocytic leukemia and other types of cancer. The oral dosage form can be administered once or twice per day and has a higher bioavailability than intravenous administration. The drug binds to specific antibodies in the bloodstream, preventing them from attaching to white blood cells, which prevents their activation and slows down the growth of cancer cells. Hydroxy bendamustine also exhibits anti-inflammatory properties by inhibiting prostaglandin synthesis.

Formula: C₁₆H₂₂ClN₃O₃

Purity: Min. 95 Area-%

Molecular weight: 339.82 g/mol

Ref: 3D-FH23910

Bendamustine USP Related Compound E

CAS: 109882-27-1

Formula: C₁₆H₂₂ClN₃O₃

Molecular weight: 339.82

Ref: ST-EA-CP-B7006